seed
Stage
2020
Founded
2
Investors
About
Haermonics is a medical device company developing a novel technology to remove free hemoglobin from the blood during and after cardiac surgery. This aims to prevent postoperative complications such as acute kidney injury.
Explore Haermonics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.